Abstract:The lack of predictive preclinical models is a fundamental barrier to translating knowledge about the molecular pathogenesis of cancer into improved therapies. Insertional mutagenesis (IM) in mice is a robust strategy for generating malignancies that recapitulate the extensive inter- and intra-tumoral genetic heterogeneity found in advanced human cancers. While the central role of "driver" viral insertions in IM models that aberrantly increase the expression of proto-oncogenes or disrupt tumor suppressors has been appreciated for many years, the contributions of cooperating somatic mutations and large chromosomal alterations to tumorigenesis are largely unknown. Integrated genomic studies of T lineage acute lymphoblastic leukemias (T-ALLs) generated by IM in wild-type (WT) and Kras mutant mice reveal frequent point mutations and other recurrent non-insertional genetic alterations that also occur in human T-ALL. These somatic mutations are sensitive and specific markers for defining clonal dynamics and identifying candidate resistance mechanisms in leukemias that relapse after an initial therapeutic response. Primary cancers initiated by IM and resistant clones that emerge during in vivo treatment close key gaps in existing preclinical models, and are robust platforms for investigating the efficacy of new therapies and for elucidating how drug exposure shapes tumor evolution and patterns of resistance. Author summary A lack of predictive cancer models is a major bottleneck for prioritizing new anti-cancer drugs for clinical trials. We comprehensively profiled a panel of primary mouse T lineage leukemias initiated by insertional mutagenesis and found remarkable similarities with human T-ALL in regard to overall mutational burden, the occurrence of specific somatic mutations and large chromosomal alterations, and concordant gene expression signatures. We observed frequent duplication of the Kras oncogene with loss of the normal allele, which has potential therapeutic implications that merit further investigation in human leukemia and in other preclinical models. Mutations identified in mouse leukemias that relapsed after in vivo treatment with signal transduction inhibitors were also observed in relapsed human T-ALL, indicating that this model system can be utilized to investigate strategies for overcoming intrinsic and acquired drug resistance. Finally, preclinical models similar to the one described here that are characterized by a normal endogenous tumor microenvironment and intact immune system will become increasingly important for testing immunotherapy approaches for human cancer.

Computational identification of insertional mutagenesis targets for cancer gene discovery

Genome-wide transposon screening and quantitative insertion site sequencing for cancer gene discovery in mice

Target identification of small molecules using large-scale CRISPR-Cas mutagenesis scanning of essential genes

In vivo functional screening for systems-level integrative cancer genomics

Identification of cancer genes using a statistical framework for multi-experiment analysis of non-discretized array CGH data (vol 36, pg 13, 2008)

Toward an integrated map of genetic interactions in cancer cells

An Evolutionary Approach for Identifying Driver Mutations in Colorectal Cancer

Systematic Analysis of Genetic Alterations in Tumors Using Cancer Genome WorkBench (CGWB).

Transposon Insertional Mutagenesis In Mice Identifies Human Breast Cancer Susceptibility Genes And Signatures For Stratification

Rapid identification of somatic mutations in colorectal and breast cancer tissues using mismatch repair detection (MRD)

Computational inference of cancer-specific vulnerabilities in clinical samples

Unlocking the Bottleneck in Forward Genetics Using Whole-Genome Sequencing and Identity by Descent to Isolate Causative Mutations

Development of an Accessible Gene Expression Bioinformatics Pipeline to Study Driver Mutations of Colorectal Cancer

CanPredict: a Computational Tool for Predicting Cancer-Associated Missense Mutations

Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis

WheresWalker: a pipeline for rapid mutation mapping using whole genome sequencing

InMut-finder: a software tool for insertion identification in mutagenesis using Nanopore long reads

Single Allele Loss-of-function Mutations Select and Sculpt Conditional Cooperative Networks in Breast Cancer

e-MutPath: computational modeling reveals the functional landscape of genetic mutations rewiring interactome networks

Convergent genetic aberrations in murine and human T lineage acute lymphoblastic leukemias.

High-throughput oncogene mutation profiling in human cancer